December 3 Biotech Update- CELG partnering and some interesting price action

The market sold off and took a number of biotechs with it, although there were some that bucked the trend. I would not read anything into the selling today as.

December 2 Biotech Update- Getting Ready for ASH

Last week ended well for biotechs and today was a little more of the same with perhaps some consolidation. News has been relatively limited as most traders/investors/general biotech followers are.

November 26 Biotech Update- MACK fails … again and Strategic Buyers Opening Wallets … again?

We are drifting towards the holiday and there is really not much action and we are fairly quiet on the news front. As such, this will be the last update.

November 25 Biotech Update- What to Make of CLDX and CBST data and the new MRK trial

The market was a low volume chop fest (although with a fairly narrow range) for the most part and I do not think we should read too much into price.

BMY – Quick Chart Update

Bristol-Myers Squibb Company (BMY)  -NYSE   Interesting price action since September 9th after breaking out the downtrend line around $41.90, we kept watching the chart day after day during the preparation.

November 22 Biotech Update- A Busy CHMP out with some Bullish News

You will notice that I am change the title to something more descriptive, hopefully you will still read the updates with this change. Sentiment is certainly shifting in the biotech.

Week’s Option Activity (11/18~11/21)

The following stocks had notable activity in their options during the past week(s): $HZNP (11/18): 1,632 FEB14 6.0 strike Calls (stock at $4.47) were purchased for 0.95 or $155,040. Buyer.

Catalyst Watch – Vol. 1, Edition 8 (11/20/13)

Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names.  Estimates, values and views are as of the date of publishing (or are.

November 20-EOD (or midday)

In terms of the sector it is more of the same with an inline to slight outperformance of the market writ large (when the market is treading water or going.

November 19- EOD

The sector was doing fine yesterday until Icahn dumped on the market and everything got caught in the crossfire. This morning they are doing fine again, so it seems that.

November 18-EOD

Thankfully there was not a lot of news but biotechs did not just drift lower. I still worry about tax loss selling hitting the sector (or at least the small.

November 15-EOD

It has been a relatively quiet day in biotech land, which is fine as it has been a busy week. I saw more of the same with a mixed performance.

November 14- EOD

It is a similar market day as earlier this week with some definite movers to the upside and downside but with nothing that is general to the sector. If anything.

Week’s Option Activity (11/6~11/13)

The following stocks had notable activity in their options during the past week(s): $MACK (11/6): 600 MAR14 2.50 strike (stock at $2.28) Calls were purchased for 0.60 or $36,000 –.

SRPT – FDA Says No To Sarepta AA

On Tuesday morning, Sarepta informed investors that in what appeared to be a change from its previous stance, the FDA was not supportive of the company’s planned Accelerated Approval filing.

November 13-EOD

It is difficult to get a real sense of where the sector is going outside of down. Obviously one could draw the conclusion that sentiment is negative (and it is).

November 12- EOD

Well, I think it was more of the same in the sector writ large with the biggest news obviously being SRPT, which I will touch on below. I was surprised.

Catalyst Watch – Vol. 1, Edition 7 (11/12/13)

Below are current tactical and strategic thoughts on approaching FDA and clinical trial catalysts for select names. Estimates, values and views are as of the date of publishing (or are.

ONTX – Looking For The Reversal Pattern

Onconova Therapeutics, Inc. (ONTX) -Nasdaq   Onconova has recently plunged about $19 from the 52-week high at $31.13, reached just a month ago to the current level in mid-$13s and reaching the.

November 11- EOD

I am gone for a little while and the market goes crazy, bounces, and then we have today which has both sell offs and rallies. To be honest, it is.

Browsing 20 / 3 articles